{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:38:40Z","timestamp":1791398320161,"version":"4.3.3"},"reference-count":37,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11,1]]},"abstract":"<jats:p>STAT5 proteins are components of the common growth hormone and interleukin 2 family of cytokines' signaling pathway. Mutations in the STAT5b gene, described in 2 patients, lead to growth hormone insensitivity that resembles Laron syndrome. Clinical immunodeficiency was also present, although immunologic defects have not been well characterized thus far. Here we describe a 16-year-old girl who suffered generalized eczema and recurrent infections of the skin and respiratory tract since birth. She also suffered severe chronic lung disease and multiple episodes of herpetic keratitis. Clinical features of congenital growth hormone deficiency were observed, such as persistently low growth rate, severely delayed bone age, and postnatal growth failure resulting from growth hormone resistance. This combined phenotype of growth hormone insensitivity and immunodeficiency was attributable to a homozygous C\u2192T transition that resulted in a nonsense mutation at codon 152 in exon 5 of the STAT5b gene. This novel mutation determined a complete absence of protein expression. The main immunologic findings were moderate T-cell lymphopenia (1274\/mm3), normal CD4\/CD8 ratio, and very low numbers of natural killer (18\/mm3) and \u03b3\u03b4 T (5\/mm3) cells. T cells presented a chronically hyperactivated phenotype. In vitro T-cell proliferation and interleukin 2 signaling were impaired. CD4+ and CD25+ regulatory T cells were significantly diminished, and they probably contributed to the signs of homeostatic mechanism deregulation found in this patient. This new case, in accordance with 2 previously reported cases, definitely demonstrates the significant role of the STAT5b protein in mediating growth hormone actions. Furthermore, the main immunologic findings bring about an explanation for the clinical immunodeficiency features and reveal for the first time the relevant role of STAT5b as a key protein for T-cell functions in humans.<\/jats:p>","DOI":"10.1542\/peds.2005-2882","type":"journal-article","created":{"date-parts":[[2006,10,10]],"date-time":"2006-10-10T00:48:06Z","timestamp":1160441286000},"page":"e1584-e1592","source":"Crossref","is-referenced-by-count":153,"title":["Characterization of Immunodeficiency in a Patient With Growth Hormone Insensitivity Secondary to a Novel <i>STAT5b<\/i> Gene Mutation"],"prefix":"10.1542","volume":"118","author":[{"given":"Andrea","family":"Bernasconi","sequence":"first","affiliation":[{"name":"Immunology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Marino","sequence":"additional","affiliation":[{"name":"Endocrinology Service, Hospital de Pediatria Garrahan, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Ribas","sequence":"additional","affiliation":[{"name":"Immunology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Rossi","sequence":"additional","affiliation":[{"name":"Immunology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ciaccio","sequence":"additional","affiliation":[{"name":"Endocrinology Service, Hospital de Pediatria Garrahan, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mati\u0301as","family":"Oleastro","sequence":"additional","affiliation":[{"name":"Immunology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Ornani","sequence":"additional","affiliation":[{"name":"Immunology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rube\u0301n","family":"Paz","sequence":"additional","affiliation":[{"name":"Immunology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Rivarola","sequence":"additional","affiliation":[{"name":"Endocrinology Service, Hospital de Pediatria Garrahan, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Zelazko","sequence":"additional","affiliation":[{"name":"Immunology Service"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Belgorosky","sequence":"additional","affiliation":[{"name":"Endocrinology Service, Hospital de Pediatria Garrahan, Buenos Aires, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,11,1]]},"reference":[{"key":"2021120823202626600_R1","doi-asserted-by":"crossref","unstructured":"Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW. Signaling through the JAK\/STAT pathway recent advances and future challenges. Gene.\u20082002;285:1\u201324","DOI":"10.1016\/S0378-1119(02)00398-0"},{"key":"2021120823202626600_R2","doi-asserted-by":"crossref","unstructured":"Liu X, Robinson GW, Gouilleux F, Groner B, Hennighausen L. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc Natl Acad Sci USA. 1995;92:8831\u20138835","DOI":"10.1073\/pnas.92.19.8831"},{"key":"2021120823202626600_R3","doi-asserted-by":"crossref","unstructured":"Teglund S, McKay C, Schuetz E, et al. Stat5a and Stat5b proteins have essential and nonessential or redundant roles in cytokine responses. Cell.\u20081998;93:841\u2013850","DOI":"10.1016\/S0092-8674(00)81444-0"},{"key":"2021120823202626600_R4","doi-asserted-by":"crossref","unstructured":"Udy GB, Towers RP, Snell RG, et al. Requirement for Stat5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci USA.\u20081997;94:7239\u20137244","DOI":"10.1073\/pnas.94.14.7239"},{"key":"2021120823202626600_R5","doi-asserted-by":"crossref","unstructured":"Kofoed EM, Hwa V, Little B, et al. Growth hormone insensitivity associated with a STAT5b mutation. N Engl J Med.\u20082003;349:1139\u20131147","DOI":"10.1056\/NEJMoa022926"},{"key":"2021120823202626600_R6","doi-asserted-by":"crossref","unstructured":"Hwa V, Little B, Adiyaman P, et al. Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. J Clin Endocrinol Metab.\u20082005;90:4260\u20134266","DOI":"10.1210\/jc.2005-0515"},{"key":"2021120823202626600_R7","doi-asserted-by":"crossref","unstructured":"Laron Z. Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958\u20132003. J Clin Endocrinol Metab.\u20081996;89:1031\u20131044","DOI":"10.1210\/jc.2003-031033"},{"key":"2021120823202626600_R8","doi-asserted-by":"crossref","unstructured":"Yao Z, Cui Y, Watford WT, et al. Stat5a\/b are essential for normal lymphoid development and differentiation. Proc Natl Acad Sci USA.\u20082006;103:1000\u20131005","DOI":"10.1073\/pnas.0507350103"},{"key":"2021120823202626600_R9","doi-asserted-by":"crossref","unstructured":"Snow JW, Abraham N, Ma MC, Herndier BG, Pastuszak AW, Goldsmith MA. Loss of tolerance and autoimmunity affecting multiple organs in Stat5a\/5b deficient mice. J Immunol.\u20082003;171:5042\u20135050","DOI":"10.4049\/jimmunol.171.10.5042"},{"key":"2021120823202626600_R10","doi-asserted-by":"crossref","unstructured":"Lord JD, McIntosh BC, Greenberg PD, Nelson BH. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc bcl-2 and bcl-x genes through the trans-activation domain of Stat5. J Immunol.\u20082000;164:2533\u20132554","DOI":"10.4049\/jimmunol.164.5.2533"},{"key":"2021120823202626600_R11","doi-asserted-by":"crossref","unstructured":"Moriggl R, Topham DJ, Teglund S, et al. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity.\u20081999;10:249\u2013259","DOI":"10.1016\/S1074-7613(00)80025-4"},{"key":"2021120823202626600_R12","doi-asserted-by":"crossref","unstructured":"Horak I, Lohl J, Ma A, Smith KA. Interleukin-2 deficient mice: a new model for studying. Immunol Rev.\u20081995;148:35\u201344","DOI":"10.1111\/j.1600-065X.1995.tb00092.x"},{"key":"2021120823202626600_R13","doi-asserted-by":"crossref","unstructured":"Willeford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. Interleukin-2 receptor \u03b1 chain regulates the size and content of the peripheral lymphoid compartment. Immunity.\u20081995;3:521\u2013530","DOI":"10.1016\/1074-7613(95)90180-9"},{"key":"2021120823202626600_R14","doi-asserted-by":"crossref","unstructured":"Suzuki H, Kundig TM, Furlonger C, et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor \u03b2. Science.\u20081995;268:1472\u20131476","DOI":"10.1126\/science.7770771"},{"key":"2021120823202626600_R15","doi-asserted-by":"crossref","unstructured":"Shevach EM. Certified professionals: CD4+CD25+ suppressor T cells. J Exp Med.\u20082001;193:F41\u2013F45","DOI":"10.1084\/jem.193.11.F41"},{"key":"2021120823202626600_R16","doi-asserted-by":"crossref","unstructured":"Imada K, Bloom ET, Nakajima H, et al. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity. J Exp Med.\u20081998;188:2067\u20132074","DOI":"10.1084\/jem.188.11.2067"},{"key":"2021120823202626600_R17","doi-asserted-by":"crossref","unstructured":"Antov A, Yang L, Vig M, Baltimore D, Van Parijs L. Essential role for Stat5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance. J Immunol.\u20082003;171:3435\u20133441","DOI":"10.4049\/jimmunol.171.7.3435"},{"key":"2021120823202626600_R18","doi-asserted-by":"crossref","unstructured":"Burchill MA, Goetz CA, Prlic MO, et al. Distinct effect of Stat5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J Immunol.\u20082003;171:5853\u20135864","DOI":"10.4049\/jimmunol.171.11.5853"},{"key":"2021120823202626600_R19","doi-asserted-by":"crossref","unstructured":"Chaler E, Belgorosky A, Maceiras M, Mendioroz M, Rivarola MA. Between-assay differences in serum growth hormone (GH) measurements: importance in the diagnosis of GH deficiency in childhood. Clin Chem.\u20082001;47:1735\u20131738","DOI":"10.1093\/clinchem\/47.9.1735"},{"key":"2021120823202626600_R20","doi-asserted-by":"crossref","unstructured":"Belgorosky A, Rivarola MA. Insulin-like growth factor binding protein (IGFBP)-3-bound IGF-I and IGFBP-3-bound IGF-II in growth hormone deficiency. Horm Res.\u20081999;52:60\u201365","DOI":"10.1159\/000023436"},{"key":"2021120823202626600_R21","unstructured":"Robinson P. Handbook of Flow Cytometry Methods. New York, NY: Wiley-Liss, Inc; 1993"},{"key":"2021120823202626600_R22","doi-asserted-by":"crossref","unstructured":"Fleisher TA, Dorman SE, Anderson JA, Vail M, Brown MR, Holland SM. Detection of intracellular phosphorylated STAT-1 by flow cytometry. Clin Immunol.\u20081999;90:425\u2013430","DOI":"10.1006\/clim.1998.4654"},{"key":"2021120823202626600_R23","doi-asserted-by":"crossref","unstructured":"Fischer MB, Hauber I, Eggenbauer H, et al. A defect in the early phase of T-cell receptor-mediated T-cell activation in patients with common variable immunodeficiency. Blood.\u20081994;84:4234\u20134241","DOI":"10.1182\/blood.V84.12.4234.bloodjournal84124234"},{"key":"2021120823202626600_R24","doi-asserted-by":"crossref","unstructured":"Baker KS, DeLaat CA, Steinbuch M, et al. Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. Blood.\u20081997;89:3857\u20133863","DOI":"10.1182\/blood.V89.10.3857"},{"key":"2021120823202626600_R25","doi-asserted-by":"crossref","unstructured":"Baecher AC, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol.\u20082001;167:1245\u20131253","DOI":"10.4049\/jimmunol.167.3.1245"},{"key":"2021120823202626600_R26","doi-asserted-by":"crossref","unstructured":"Ma FY, Anderson GM, Gunn TD, Goffin V, Grattan DR, Bunn SJ. Prolactin specifically activates signal transducer and activator of transcription 5b in neuroendocrine dopaminergic neurons. Endocrinology.\u20082005;146:5112\u20135119","DOI":"10.1210\/en.2005-0770"},{"key":"2021120823202626600_R27","doi-asserted-by":"crossref","unstructured":"Grattan DR, Xu J, McLachlan MJ, et al. Feedback regulation of PRL secretion is mediated by the transcription factor, signal transducer, and activator of transcription 5b. Endocrinology.\u20082001;142:3935\u20133940","DOI":"10.1210\/endo.142.9.8385"},{"key":"2021120823202626600_R28","doi-asserted-by":"crossref","unstructured":"Suzuki H, Duncan GS, Takimoto H, Mark TW. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL2 receptor \u03b2 chain. J Exp Med.\u20081997;185:499\u2013505","DOI":"10.1084\/jem.185.3.499"},{"key":"2021120823202626600_R29","doi-asserted-by":"crossref","unstructured":"Welte T, Leitenberg D, Dittel BN, et al. STAT5 interaction with the T cell receptor complex and stimulation of T cell proliferation. Science.\u20081999;283:222\u2013225","DOI":"10.1126\/science.283.5399.222"},{"key":"2021120823202626600_R30","doi-asserted-by":"crossref","unstructured":"John S, Robbins CM, Leonard WJ. An IL-2 response element in the human IL-2 receptor alpha chain promoter is a composite element that binds Stat5 Elf-1 HMG-I(Y) and a GATA family protein. EMBO J.\u20081996;15:5627\u20135635","DOI":"10.1002\/j.1460-2075.1996.tb00947.x"},{"key":"2021120823202626600_R31","doi-asserted-by":"crossref","unstructured":"Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell.\u20081993;75:253\u2013261","DOI":"10.1016\/0092-8674(93)80067-O"},{"key":"2021120823202626600_R32","doi-asserted-by":"crossref","unstructured":"Malek TR. The main function of IL-2 to promote the development of T regulatory cells. J Leukoc Biol.\u20082003;74:961\u2013965","DOI":"10.1189\/jlb.0603272"},{"key":"2021120823202626600_R33","doi-asserted-by":"crossref","unstructured":"Cooper MA, Bush JE, Fehniger TA, et al. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood.\u20082002;100:3633\u20133638","DOI":"10.1182\/blood-2001-12-0293"},{"key":"2021120823202626600_R34","doi-asserted-by":"crossref","unstructured":"Zhou J, Zhang J, Lichtenheld MG, Meadows GG. A role for NF-KB activation in perforin expression of NK cells upon IL-2 receptor signaling. J Immunol.\u20082002;169:1319\u20131325","DOI":"10.4049\/jimmunol.169.3.1319"},{"key":"2021120823202626600_R35","doi-asserted-by":"crossref","unstructured":"Brown MG, Dokun AO, Heusel JW, et al. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science.\u20082001;292:934\u2013937","DOI":"10.1126\/science.1060042"},{"key":"2021120823202626600_R36","doi-asserted-by":"crossref","unstructured":"Biron CA, Byron KS, Sullivan JL. Severe herpes virus infections in an adolescent without natural killer cells. N Engl J Med.\u20081989;320:1731\u20131735","DOI":"10.1056\/NEJM198906293202605"},{"key":"2021120823202626600_R37","doi-asserted-by":"crossref","unstructured":"Etzioni A, Eidenschen C, Katzk R, BeckR, Casanova JL, Pollac S. Fatal Varicella associated with selective Natural Killer cell deficiency. J Pediatr.\u20082005;146:423\u2013425","DOI":"10.1016\/j.jpeds.2004.11.022"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/5\/e1584\/1117705\/zpe011060e1584.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/5\/e1584\/1117705\/zpe011060e1584.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T03:36:37Z","timestamp":1639020997000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/5\/e1584\/69915\/Characterization-of-Immunodeficiency-in-a-Patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,1]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,11,1]]},"published-print":{"date-parts":[[2006,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-2882","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,1]]}}}